Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Thermo Fisher Scientific Inc. (TMO) had Days Sales in Receivables of 75.27 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$11.01B |
|
$1.65B |
|
$6.58B |
|
$4.43B |
|
$9.14B |
|
$1.86B |
|
$-130.00M |
|
$1.73B |
|
$1.73B |
|
$1.66B |
|
$1.66B |
|
$1.66B |
|
$1.66B |
|
$1.86B |
|
$2.60B |
|
372.00M |
|
373.00M |
|
$4.44 |
|
$4.43 |
|
| Balance Sheet Financials | |
$22.32B |
|
$10.66B |
|
$90.96B |
|
$113.28B |
|
$14.62B |
|
$40.07B |
|
$46.72B |
|
$61.34B |
|
$51.94B |
|
$-22.39B |
|
$51.94B |
|
371.62M |
|
| Cash Flow Statement Financials | |
$1.19B |
|
$-8.96B |
|
$1.09B |
|
$9.88B |
|
$3.28B |
|
$-6.60B |
|
$83.00M |
|
$-162.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
0.44 |
|
0.83 |
|
40.25% |
|
16.94% |
|
16.94% |
|
-- |
|
15.76% |
|
15.00% |
|
$825.00M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.20 |
|
1.20 |
|
|
Days Sales in Receivables |
75.27 |
3.19% |
|
-7.40% |
|
1.46% |
|
1.80% |
|
$139.77 |
|
$2.21 |
|
$3.20 |
|